DEFECTIVE DEVELOPMENT OF THE CRANIOFACIAL DIGESTIVE COMPLEX OF XENOPUS-LAEVIS AFTER TREATMENT WITH ENDOGENOUS GALACTOSIDE-BINDING LECTIN ORITS HAPTEN INHIBITOR THIODIGALACTOSIDE/
Pv. Varma et al., DEFECTIVE DEVELOPMENT OF THE CRANIOFACIAL DIGESTIVE COMPLEX OF XENOPUS-LAEVIS AFTER TREATMENT WITH ENDOGENOUS GALACTOSIDE-BINDING LECTIN ORITS HAPTEN INHIBITOR THIODIGALACTOSIDE/, Journal of craniofacial genetics and developmental biology, 14(3), 1994, pp. 177-191
The regions of the developing craniofacial skeleton and gut of Xenopus
laevis have been confronted in vivo with purified embryonic galactosi
de-binding lectin or its hapten inhibitor thiodigalactoside (TDG). Con
frontation was carried out at stage 24-26 (cranial neural crest migrat
ing). Further development of the head skeleton and gut has been monito
red in living animals and in histological cross-sections of selected h
ead regions. Lectin treatment correlates with the development of large
r heads than controls. TDG treatment correlates with the development o
f narrower heads than controls. After both treatments, head cartilages
are composed of fewer total chondrocytes. Both neural crest and non-n
eural crest cartilages are affected. The gut forms larger, irregular c
oils after lectin or TDG confrontation. The results suggest that galac
toside-binding lectin/galactoside-bearing receptor adhesive interactio
ns are important in development of the craniofacial/visceral skeleton
and gut.